New RA drug from BMS gains recommendation

September 7, 2005
Sales and Marketing

A new treatment for rheumatoid arthritis from Bristol-Myers Squibb has received recommendation approval from an FDA committee, bringing it one …

Advertising workshop

September 7, 2005
Medical Communications

The investment risk in developing a profitable brand is huge and with every new brand launch comes escalating expectations. At …

The evolving world of advertising

September 6, 2005
Medical Communications

The considerable challenges facing pharma companies over the past few years have taken centre stage in analysis of healthcare marketing: …

Junior doctors to be taught communication skills

September 6, 2005

Newly qualified doctors will have to take a new training programme to teach them soft skills, such as how to …

Scientists back testing after guinea pig breeder forced to close

September 6, 2005
Research and Development

UK scientists have rallied to support animal research after a six-year campaign against Staffordshire guinea pig breeder Darley Oaks Farm …

Pfizer demands action after more fake Lipitor found in UK

September 6, 2005
Manufacturing and Production

The MHRA has discovered a second batch of counterfeit Lipitor in under a month, a worrying indication of a growing …

$1 billion Cialis closing on Viagra

September 6, 2005
Sales and Marketing

Erectile dysfunction drug Cialis has achieved cumulative sales of $1 billion and is closing the gap on Pfizer's market leader …

All new product marketing to be pre-vetted in UK

September 2, 2005
Medical Communications, Sales and Marketing

Advertising and marketing materials for all new products are to be vetted by the UK regulator for the accuracy of …

New NHS early warning system for long-term conditions

September 2, 2005

A new computer program will give NHS clinicians an early warning about patients at risk of being admitted to hospital.The …

Takeda’s dependence-free sleeping pill approved

September 2, 2005
Research and Development, Sales and Marketing

A new sleeping pill which patients cannot abuse or become dependent on has been approved in the US.Takeda's Rozerem (ramelteon) …

GP contract hailed as great success

September 2, 2005

GPs in England have been hailed as world leaders in chronic disease management by the government following the release of …

Mixed news for Lilly’s neuropathy drug

August 23, 2005

Lilly says it will file its new treatment for diabetic retinopathy with regulators by the end of the year – …

Schering’s new low-dose contraceptive approved in Netherlands

August 19, 2005
Sales and Marketing

Yasminelle, a new low-dose oral contraceptive from Schering has received its first European marketing approval in the Netherlands. The country …

Recovery of healthcare PR highlights recruitment needs

August 18, 2005
Medical Communications

The mood of optimism in healthcare PR is set to continue following an average 15% growth among agencies' net income …

Second batch of fake Lipitor discovered

August 18, 2005
Manufacturing and Production

The MHRA has discovered a second batch of counterfeit Lipitor in under a month, a worrying indication of a growing …

Pfizer acquires antibody optimisation company

August 17, 2005
Research and Development

Pfizer has purchased a company that develops technology to optimise antibodies to help it identify and develop new drugs with …

Acambis developing universal flu vaccine

August 17, 2005
Research and Development

Acambis has started developing a flu vaccine that could alter the market by offering permanent protection against influenza and guarding …

The Gateway to Local Adoption Series

Latest content